586 related articles for article (PubMed ID: 26644378)
21. Infection-Induced Resistance to Experimental Cerebral Malaria Is Dependent Upon Secreted Antibody-Mediated Inhibition of Pathogenic CD8
Shaw TN; Inkson CA; Villegas-Mendez A; Pattinson DJ; Strangward P; Else KJ; Draper SJ; Zeef LAH; Couper KN
Front Immunol; 2019; 10():248. PubMed ID: 30846985
[TBL] [Abstract][Full Text] [Related]
22. IRGM3 contributes to immunopathology and is required for differentiation of antigen-specific effector CD8+ T cells in experimental cerebral malaria.
Guo J; McQuillan JA; Yau B; Tullo GS; Long CA; Bertolino P; Roediger B; Weninger W; Taylor GA; Hunt NH; Ball HJ; Mitchell AJ
Infect Immun; 2015 Apr; 83(4):1406-17. PubMed ID: 25644000
[TBL] [Abstract][Full Text] [Related]
23. Coincident parasite and CD8 T cell sequestration is required for development of experimental cerebral malaria.
McQuillan JA; Mitchell AJ; Ho YF; Combes V; Ball HJ; Golenser J; Grau GE; Hunt NH
Int J Parasitol; 2011 Feb; 41(2):155-63. PubMed ID: 20828575
[TBL] [Abstract][Full Text] [Related]
24. THEMIS is required for pathogenesis of cerebral malaria and protection against pulmonary tuberculosis.
Torre S; Faucher SP; Fodil N; Bongfen SE; Berghout J; Schwartzentruber JA; Majewski J; Lathrop M; Cooper AM; Vidal SM; Gros P
Infect Immun; 2015 Feb; 83(2):759-68. PubMed ID: 25452553
[TBL] [Abstract][Full Text] [Related]
25. Natural regulatory T cells mediate the development of cerebral malaria by modifying the pro-inflammatory response.
Wu JJ; Chen G; Liu J; Wang T; Zheng W; Cao YM
Parasitol Int; 2010 Jun; 59(2):232-41. PubMed ID: 20219695
[TBL] [Abstract][Full Text] [Related]
26. Minocycline prevents cerebral malaria, confers neuroprotection and increases survivability of mice during Plasmodium berghei ANKA infection.
Apoorv TS; Babu PP
Cytokine; 2017 Feb; 90():113-123. PubMed ID: 27865203
[TBL] [Abstract][Full Text] [Related]
27. Malaria-specific and nonspecific activation of CD8+ T cells during blood stage of Plasmodium berghei infection.
Miyakoda M; Kimura D; Yuda M; Chinzei Y; Shibata Y; Honma K; Yui K
J Immunol; 2008 Jul; 181(2):1420-8. PubMed ID: 18606696
[TBL] [Abstract][Full Text] [Related]
28. ZBTB7B (ThPOK) Is Required for Pathogenesis of Cerebral Malaria and Protection against Pulmonary Tuberculosis.
Kennedy JM; Georges A; Bassenden AV; Vidal SM; Berghuis AM; Taniuchi I; Majewski J; Lathrop M; Behr MA; Langlais D; Gros P
Infect Immun; 2020 Jan; 88(2):. PubMed ID: 31792077
[TBL] [Abstract][Full Text] [Related]
29. CD4+ CD25+ regulatory T cells suppress CD4+ T-cell function and inhibit the development of Plasmodium berghei-specific TH1 responses involved in cerebral malaria pathogenesis.
Nie CQ; Bernard NJ; Schofield L; Hansen DS
Infect Immun; 2007 May; 75(5):2275-82. PubMed ID: 17325053
[TBL] [Abstract][Full Text] [Related]
30. Cutting edge: selective blockade of LIGHT-lymphotoxin beta receptor signaling protects mice from experimental cerebral malaria caused by Plasmodium berghei ANKA.
Randall LM; Amante FH; Zhou Y; Stanley AC; Haque A; Rivera F; Pfeffer K; Scheu S; Hill GR; Tamada K; Engwerda CR
J Immunol; 2008 Dec; 181(11):7458-62. PubMed ID: 19017933
[TBL] [Abstract][Full Text] [Related]
31. An experimental model to study tuberculosis-malaria coinfection upon natural transmission of Mycobacterium tuberculosis and Plasmodium berghei.
Mueller AK; Behrends J; Blank J; Schaible UE; Schneider BE
J Vis Exp; 2014 Feb; (84):e50829. PubMed ID: 24637905
[TBL] [Abstract][Full Text] [Related]
32. Perforin-dependent brain-infiltrating cytotoxic CD8+ T lymphocytes mediate experimental cerebral malaria pathogenesis.
Nitcheu J; Bonduelle O; Combadiere C; Tefit M; Seilhean D; Mazier D; Combadiere B
J Immunol; 2003 Feb; 170(4):2221-8. PubMed ID: 12574396
[TBL] [Abstract][Full Text] [Related]
33. Attenuated T Cell Responses Are Associated With the Blockade of Cerebral Malaria Development by YOP1-Deficient
Hai L; Shi X; Wang Q
Front Immunol; 2021; 12():642585. PubMed ID: 34025654
[TBL] [Abstract][Full Text] [Related]
34. Immune-mediated mechanisms of parasite tissue sequestration during experimental cerebral malaria.
Amante FH; Haque A; Stanley AC; Rivera Fde L; Randall LM; Wilson YA; Yeo G; Pieper C; Crabb BS; de Koning-Ward TF; Lundie RJ; Good MF; Pinzon-Charry A; Pearson MS; Duke MG; McManus DP; Loukas A; Hill GR; Engwerda CR
J Immunol; 2010 Sep; 185(6):3632-42. PubMed ID: 20720206
[TBL] [Abstract][Full Text] [Related]
35. Mycobacterium-induced potentiation of type 1 immune responses and protection against malaria are host specific.
Page KR; Jedlicka AE; Fakheri B; Noland GS; Kesavan AK; Scott AL; Kumar N; Manabe YC
Infect Immun; 2005 Dec; 73(12):8369-80. PubMed ID: 16299335
[TBL] [Abstract][Full Text] [Related]
36. Eosinophils Suppress the Migration of T Cells Into the Brain of
Scheunemann JF; Reichwald JJ; Korir PJ; Kuehlwein JM; Jenster LM; Hammerschmidt-Kamper C; Lewis MD; Klocke K; Borsche M; Schwendt KE; Soun C; Thiebes S; Limmer A; Engel DR; Mueller AK; Hoerauf A; Hübner MP; Schumak B
Front Immunol; 2021; 12():711876. PubMed ID: 34659202
[TBL] [Abstract][Full Text] [Related]
37. Brain microvessel cross-presentation is a hallmark of experimental cerebral malaria.
Howland SW; Poh CM; Gun SY; Claser C; Malleret B; Shastri N; Ginhoux F; Grotenbreg GM; Rénia L
EMBO Mol Med; 2013 Jul; 5(7):984-99. PubMed ID: 23681698
[TBL] [Abstract][Full Text] [Related]
38. Early cytokine production is associated with protection from murine cerebral malaria.
Mitchell AJ; Hansen AM; Hee L; Ball HJ; Potter SM; Walker JC; Hunt NH
Infect Immun; 2005 Sep; 73(9):5645-53. PubMed ID: 16113282
[TBL] [Abstract][Full Text] [Related]
39. Protein kinase C θ deficiency increases resistance of C57BL/6J mice to Plasmodium berghei infection-induced cerebral malaria.
Ohayon A; Golenser J; Sinay R; Tamir A; Altman A; Pollack Y; Isakov N
Infect Immun; 2010 Oct; 78(10):4195-205. PubMed ID: 20660606
[TBL] [Abstract][Full Text] [Related]
40. Development of a Novel CD4
Fernandez-Ruiz D; Lau LS; Ghazanfari N; Jones CM; Ng WY; Davey GM; Berthold D; Holz L; Kato Y; Enders MH; Bayarsaikhan G; Hendriks SH; Lansink LIM; Engel JA; Soon MSF; James KR; Cozijnsen A; Mollard V; Uboldi AD; Tonkin CJ; de Koning-Ward TF; Gilson PR; Kaisho T; Haque A; Crabb BS; Carbone FR; McFadden GI; Heath WR
J Immunol; 2017 Dec; 199(12):4165-4179. PubMed ID: 29084838
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
